Compared with subjects without DM, those with DM were more likely to have hypertension, peripheral artery disease (PAD) and previous stroke, and to be treated with angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) (Table 1 and Table 2). Here, ACE is linked to peripheral arterial disease.